Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential

被引:121
作者
Dawson, Kristin [1 ,4 ]
Aflaki, Mona [1 ,4 ]
Nattel, Stanley [1 ,2 ,3 ,4 ]
机构
[1] Montreal Heart Inst, Res Ctr, Quebec City, PQ, Canada
[2] Montreal Heart Inst, Dept Med, Quebec City, PQ, Canada
[3] Univ Montreal, Quebec City, PQ, Canada
[4] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2013年 / 591卷 / 06期
关键词
GLYCOGEN-SYNTHASE KINASE-3-BETA; MESENCHYMAL STEM-CELLS; MAMMARY ONCOGENE INT-1; N-TERMINAL KINASE; BETA-CATENIN; SIGNALING PATHWAY; HEART-FAILURE; MYOCARDIAL-INFARCTION; DIFFERENTIAL ACTIVATION; NEGATIVE REGULATOR;
D O I
10.1113/jphysiol.2012.235382
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The Wnt-Frizzled (Fzd) G-protein-coupled receptor system, involving 19 distinct Wnt ligands and 10 Fzd receptors, plays key roles in the development and functioning of many organ systems. There is increasing evidence that Wnt-Fzd signalling is important in regulating cardiac function. Wnt-Fzd signalling primarily involves a canonical pathway, with dishevelled-1-dependent nuclear translocation of -catenin that derepresses Wnt-sensitive gene transcription, but can also include non-canonical pathways via phospholipase-C/Ca2+ mobilization and dishevelled-protein activation of small GTPases. Wnt-Fzd effects vary with specific ligand/receptor interactions and associated downstream pathways. This paper reviews the biochemistry and physiology of the Wnt-Fzd complex, and presents current knowledge of Wnt signalling in cardiac remodelling processes such as hypertrophy and fibrosis, as well as disease states such as myocardial infarction (MI), heart failure and arrhythmias. Wnt signalling is activated during hypertrophy; inhibiting Wnt signalling by activating glycogen synthase kinase attenuates the hypertrophic response. Wnt signalling has complex and time-dependent actions post-MI, so that either beneficial or harmful effects might result from Wnt-directed interventions. Stem cell biology, a promising area for therapeutic intervention, is highly regulated by Wnt signalling. The Wnt system regulates fibroblast function, and is prominently altered in arrhythmogenic ventricular cardiomyopathy, a familial disease involving excess deposition of fibroadipose tissue. Wnt signalling controls connexin43 expression, thereby contributing to the regulation of cardiac electrical stability and arrhythmia generation. Although much has been learned about Wnt-Fzd signalling in hypertrophy and infarction, its role is poorly understood for a broad range of other heart disorders. Much more needs to be learned for its contributions to be fully appreciated, and to permit more effective exploitation of its enormous potential in therapeutic development.
引用
收藏
页码:1409 / 1432
页数:24
相关论文
共 201 条
[1]   Molecular targets and regulators of cardiac hypertrophy [J].
Agrawal, Rohini ;
Agrawal, Neeraj ;
Koyani, Chintan N. ;
Singh, Randhir .
PHARMACOLOGICAL RESEARCH, 2010, 61 (04) :269-280
[2]   Wnt-1 regulation of connexin43 in cardiac myocytes [J].
Ai, ZW ;
Fischer, A ;
Spray, DC ;
Brown, AMC ;
Fishman, GI .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) :161-171
[3]   Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition [J].
Aisagbonhi, Omonigho ;
Rai, Meena ;
Ryzhov, Sergey ;
Atria, Nick ;
Feoktistov, Igor ;
Hatzopoulos, Antonis K. .
DISEASE MODELS & MECHANISMS, 2011, 4 (04) :469-483
[4]   Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis [J].
Akhmetshina, Alfiya ;
Palumbo, Katrin ;
Dees, Clara ;
Bergmann, Christina ;
Venalis, Paulius ;
Zerr, Pawel ;
Horn, Angelika ;
Kireva, Trayana ;
Beyer, Christian ;
Zwerina, Jochen ;
Schneider, Holm ;
Sadowski, Anika ;
Riener, Marc-Oliver ;
MacDougald, Ormond A. ;
Distler, Oliver ;
Schett, Georg ;
Distler, Joerg H. W. .
NATURE COMMUNICATIONS, 2012, 3
[5]   Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo [J].
Antos, CL ;
McKinsey, TA ;
Frey, N ;
Kutschke, W ;
McAnally, J ;
Shelton, JM ;
Richardson, JA ;
Hill, JA ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :907-912
[6]  
ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169
[7]  
Ballon DR, 2006, CELL, V126, P1079, DOI 10.1016/j.cell.2006.07.030
[8]   Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning [J].
Barandon, L ;
Dufourcq, P ;
Costet, P ;
Moreau, C ;
Allières, C ;
Daret, D ;
Dos Santos, P ;
Lamazière, JMD ;
Couffinhal, T ;
Duplàa, C .
CIRCULATION RESEARCH, 2005, 96 (12) :1299-1306
[9]   Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA [J].
Barandon, L ;
Couffinhal, T ;
Ezan, J ;
Dufourcq, P ;
Costet, P ;
Alzieu, P ;
Leroux, L ;
Moreau, C ;
Dare, D ;
Duplàa, C .
CIRCULATION, 2003, 108 (18) :2282-2289
[10]   Secreted Frizzled-Related Protein-1 Improves Postinfarction Scar Formation Through a Modulation of Inflammatory Response [J].
Barandon, Laurent ;
Casassus, Frederic ;
Leroux, Lionel ;
Moreau, Catherine ;
Allieres, Cecile ;
Lamaziere, Jean-Marie Daniel ;
Dufourcq, Pascale ;
Couffinhal, Thierry ;
Duplaa, Cecile .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (11) :E80-U60